Sur180 Therapeutics Featured on Notiséis WIPR

On March 27, 2026, Sur180 Therapeutics Co-Founder and CEO, Dr. Annelyn Torres-Reverón, was interviewed on Notiséis WIPR by journalist Mayra Acevedo. The conversation highlighted Sur180’s mission and the development of a novel non-hormonal treatment for endometriosis.

This feature marks another milestone in bringing awareness to the urgent need for better endometriosis treatments and the science being developed right here in Puerto Rico.

Watch the full interview below.

Watch Here